Skip to main content

Advertisement

SpringerLink
Log in

About MET expression and other biomarkers in non-small cell lung cancer

  • Letter to the Editor
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sterlacci W, Fiegl M, Gugger M, Budendorf L, Savic S, Tzankov A (2017) MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLC. Virchows Arch 471:49–55

    Article  CAS  PubMed  Google Scholar 

  2. Spigel DR, Ervin TJ, Ramlau A, Daniel DB, Goldschmidt JH Jr, Blumenschein GR Jr, Krzakowski MJ, Robinet G, Godbert B, Barlesi F, Govindan R, Patel T, Orlov SV, Wertheim MS, Yu W, Zha J, Yauch RL, Patel RH, Phan SC, Peterson AC (2013) Randomized phase II trial of onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol 31:4105–4114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Drilon A, Cappuzzo F, Si O, Camidge DR (2017) Targeting MET in lung cancer: will expectations finally be MET? J Thor Oncol 12:15–26

    Article  Google Scholar 

  4. Vassal G, Ledeley MC, Tournigand C, Aparicio T, Ray-Coquard I, Taillandier L, Escudier B, You B, Goncalves A, Lombard Bohas B, Seitz JF, André T, Merlio JP, Arnould L, Ferretti G, Menu Y, Mortier T, Lonchamp E, Mahier-Ait Oukhatar C, Moro-Sibilot D (2015) Activity of crizotinib in relapsed MET amplified malignancies: results of the French AcSé program. 2015 ASCO Conference. www.unicancer.fr/sites/default/files/PosterUNICANCER_TUMEUR-AMPLIFIED_ASCO%202015.pdf

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, CHRU Brest, 29220, Brest, France

    Laetitia Lambros, Isabelle Quintin-Roué, Briac Guibourg & Arnaud Uguen

  2. Inserm, U1078, 29200, Brest, France

    Arnaud Uguen

  3. Department of Pathology, University Hospital Morvan, 2, Avenue Foch, 29609, Brest, France

    Arnaud Uguen

Authors
  1. Laetitia Lambros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabelle Quintin-Roué
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Briac Guibourg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arnaud Uguen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arnaud Uguen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest and no source of funding in this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lambros, L., Quintin-Roué, I., Guibourg, B. et al. About MET expression and other biomarkers in non-small cell lung cancer. Virchows Arch 471, 685–686 (2017). https://doi.org/10.1007/s00428-017-2229-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-017-2229-5

Search

Navigation